Nachbagauer R, Feser J, Naficy A, Bernstein DI, et al. A chimeric hemagglutinin-based universal influenza virus vaccine approach induces
broad and long-lasting immunity in a randomized, placebo-controlled phase I
trial. Nat Med 2020 Dec 7. pii: 10.1038/s41591-020-1118.
PMID: 33288923